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Background: Exercise during hemodialysis treatments improves physical function, markers of cardiovascular disease
and quality of life. However, exercise programs are not a part of standard therapy in the vast majority of
hemodialysis clinics internationally. Hemodialysis unit-based accredited exercise physiologists may contribute to an
increased intradialytic exercise uptake and improved physical function.
Methods and design: This is a stepped wedge cluster randomised controlled trial design. A total of 180
participants will be recruited from 15 community satellite hemodialysis clinics in a large metropolitan Australian city.
Each clinic will represent a cluster unit. The stepped wedge design will consist of three groups each containing five
randomly allocated cluster units, allocated to either 12, 24 or 36 weeks of the intervention. The intervention will
consist of an accredited exercise physiologist-coordinated program consisting of six lower body resistance exercises
using resistance elastic bands and tubing. The resistance exercises will include leg abduction, plantar flexion, dorsi
flexion, straight-leg/bent-knee raise, knee extension and knee flexion. The resistance training will incorporate the
principle of progressive overload and completed in a seated position during the first hour of hemodialysis
treatment. The primary outcome measure is objective physical function measured by the 30-second sit to stand
test. Secondary outcome measures include the 8-foot timed-up-and-go test, the four square step test, quality of life,
cost-utility analysis, uptake and involvement in community activity, self-reported falls, fall’s confidence, medication
use, blood pressure and morbidity (hospital admissions).
Discussion: The results of this study are expected to determine the efficacy of an accredited exercise physiologist
supervised resistance training on the physical function of people receiving hemodialysis and the cost-utility of
exercise physiologists in hemodialysis centres. This may contribute to intradialytic exercise as standard therapy
using an exercise physiologist workforce model.
Trial registration: Current Controlled Trials ACTRN12612001223820.
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End stage kidney disease leads to accelerated physical
deterioration, decreased mobility, decreased capacity for
independence and an increased risk of falling [1,2]. Pre-
vious research indicates that 40% of people receiving
hemodialysis treatment have a significant falls-related in-
jury each year, with 54% of these resulting in fractures
[3]. A recent Cochrane Review confirmed that exercising
at least three times per week for greater than 30 minutes
per session for people with end stage kidney disease was
effective for improving physical fitness, walking capacity,
blood pressure and health-related quality of life [4].
Despite this, there are very few hemodialysis centres that
provide intradialytic exercise programs as standard ther-
apy [5,6]. A major contributing factor to this is the lack
of professional exercise expertise of the hemodialysis
nurses and technicians in the hemodialysis clinics [7]. In
Australia, accredited exercise physiologists (AEPs) are
masters level university trained allied health profes-
sionals who specialize in prescribing safe and effective
exercise programs to clinical populations at high risk of
developing, or with one or more, chronic diseases [8]. A
recent study reported that without the introduction of
qualified exercise professionals, exercise programs in
hemodialysis clinics are unlikely to be sustainable [9].
To our knowledge, no research study using a stepped
wedge randomised controlled design has been under-
taken to examine the effect of an exercise physiologist-
coordinated resistance exercise program for people
attending hemodialysis clinics. Although our previous
pilot studies suggest that exercise physiologists can in-
crease exercise participation in hemodialysis clinics
[10,11], the small sample size and short duration of
these studies limited the conclusions that could be
drawn. Thus a larger more rigorous trial is required to
confirm the pilot data.
The primary objective of this research is to measure
the effect of an AEP-coordinated exercise program on
physical function determined by the 30-second sit to
stand test. Secondary outcome measures include the 8-
foot timed-up-and-go test, the four square step test,
quality of life, cost-utility analysis, uptake and involve-
ment in community activity, self-reported falls, fall’s con-
fidence, medication use, blood pressure and morbidity
(hospital admissions).
It is hypothesised that an AEP-coordinated exercise
program will improve the physical function of people
with end stage kidney disease who are receiving
hemodialysis. This work is expected to be significant
given the effects of end stage kidney disease on muscu-
loskeletal health and the high number of severe falls in
this group. The current absence of exercise programs in
outpatient hemodialysis clinics (commonly known as
satellite hemodialysis clinics) means there are fewsustained exercise programs in Australia or internation-
ally, leading to a decline in hemodialysis patients’ phys-
ical function and quality of life, and increased costs to
health services.
Methods
Study design and setting
This study will use a stepped wedge cluster randomised
controlled trial design. This method is a form of ran-
domised controlled trial where randomisation occurs while
still allowing all participants the opportunity to undertake
a period of intervention [12]. In this study, the randomisa-
tion will occur at a clinic level rather than individual
participant level. Participants will be recruited from 15
community satellite hemodialysis clinics across five
healthcare organisations in Melbourne, Australia. Each
clinic will represent a cluster unit. The stepped wedge
design will consist of three groups each containing five
randomly allocated cluster units. The first group will
receive 36 weeks of the AEP-coordinated exercise inter-
vention, the second group will receive 24 weeks, and the
third group will receive 12 weeks. The study will be
conducted over a 48 week period, incorporating a
12 week pre-intervention period. The study design
was reviewed by the Australian New Zealand Clinical
Trials Registry (ANZCTR), approved and registered as
ACTRN12612001223820 on the 19th November, 2012.
Ethical considerations
The study has been approved by all five intervention health
network ethics committees and the Chief Investigator’s uni-
versity ethics committee: Southern Health Human Research
Ethics Committee (#12376B), Deakin University Human
Research Ethics Committee (#2013-024), Eastern Health
Human Research Ethics Committee (#E43-1213), Fresenius
Nephrocare Medical Affairs Department (#4313), Austin
Health Research Ethics Unit (#H2013/04990) and Alfred
Hospital Ethics Committee (#87/13).
Participants will be asked to sign two separate consent
forms; one will document their consent to participate in
the intervention and evaluation (general consent) and
the second will document their specific consent for the
researchers to request data from Medicare Australia
about medical services accessed and medications pre-
scribed for the duration of the study (Medicare consent).
All participants will be asked to sign both consent forms,
but they may still be recruited into the study if they de-
cline to sign the second form. This means that they will
participate in all other aspects of the intervention and
evaluation but their Medicare data will not be accessed.
Recruitment of participants
Flyers advertising the study will be placed on patient
noticeboards in each of the clinics from which participants
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ested in participating will be advised to contact their nurse
clinic manager or the research team directly. Once they
have registered their interest, a research assistant com-
pletely independent of the hemodialysis clinic will speak
with the patient in person at a subsequent hemodialysis
treatment. The research assistant will provide a verbal
explanation of the study and also a copy of the Partici-
pant Information and Consent Form. The patients will
be advised to read the information and encouraged to
take it home to relatives and significant others to dis-
cuss if preferred. If they choose to participate they willRecruitment – Inclusion criteria:
- 18 years of age and over
- Person with end stage renal disease
- Receiving hemodialysis for more than 12 week
- Able to understand and speak English
- Pregnant
- Lower limb ampute
- Hospitalised within
- Contraindicated on
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Figure 1 Flow chart of trial.return their completed consent form to a secured box
in the hemodialysis clinic.
Inclusion and exclusion criteria
Participants will be included in the study if they have
end stage renal disease and are receiving hemodialysis,
are aged 18 years and over, able to understand and
speak English and on hemodialysis greater than 12 weeks
(Figure 1). People will be excluded if they are pregnant,
have had lower limb amputation or have been hos-
pitalised in the four weeks prior to study commence-
ment. Additionally, the medical Head of Nephrology ats
Exclusion criteria:
e
 past 4 weeks
 medical grounds (Medical Head of Nephrology)
ot yet commenced for any group
up 1 – intervention commences
up 2 – no intervention
up 3 – no intervention
up 1 – intervention continues
up 2 – intervention commences
up 3 – no intervention
 1 – intervention continues
 2 – intervention continues
p 3 – intervention commences
Three groups of five clinics
Group 1 – 36 week intervention
Group 2 – 24 week intervention
Group 3 – 12 week intervention
Intervention
Completed
no more intervention for any group)
Table 1 Outcome measures
Data collected at 0, 12, 24, and 36 and 48 weeks
Physical function • 30 second sit and stand test
• 8 foot up and go
• 4 square step test
Involvement in
community activities
• Frenchay activities index
• Dialysis exercise adequacy
Falls • Boston falls calendar
• Modified falls efficacy scale
Biochemistry and
dialysis treatment
• Midweek pre-dialysis serum phosphate,
serum calcium, potassium, urea, creatinine,
albumin, urea reduction ratio
• Midweek pre-dialysis blood pressure
• Post-dialysis weight
Cost utility analysis • Hospital admissions: Number, reason for
admission, length of stay
• Medications
• Kidney dialysis quality of life – short form
• Utilisation of non-Medicare health services
(e.g., physiotherapy, district nursing)
• Pharmaceutical benefits scheme*
• Medical benefits schedule*
*Data collected only at 48 weeks.
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not suitable on medical grounds for the intervention.
Randomization
An individual not associated with the trial will perform
the randomization using the Microsoft Office Excel™
computer-generated random number system. Each clus-
ter (each dialysis clinic) will be randomly prescribed a
number and the five clinics with the 5 lowest numbers
will be designated into Group 1 (receiving 36 weeks of
the exercise intervention), numbers 6–10 will be allo-
cated to Group 2 (receiving 24 weeks of the exercise
intervention) and the final 5 clinics will be allocated to
Group 3 (receiving 12 weeks of the exercise interven-
tion). Allocation will be concealed at the time of partici-
pant consent; however the participants and clinic staff
will be made aware of their group at the commencement
of the intervention. Blinding of intervention group num-
ber to clinical staff and dialysis patient participants will
not be possible once the intervention commences.
Intervention
Accredited exercise physiologists (AEPs) will be appointed
to each hemodialysis clinic six hours per week per clinic for
the duration of the intervention. Depending on which
group the hemodialysis clinics are randomised to, partici-
pants will receive an exercise program that is implemented
for 12, 24 or 36 weeks. Each participant will be assessed by
an AEP who will develop an individualised exercise pro-
gram [10]. Consistent with our previous pilot study, a typ-
ical program will consist of six lower body resistance
exercises using elastic bands and tubing. The exercise pro-
gram will be done during the first hour of hemodialysis
treatment. When participants are able to perform two sets
of 15–20 repetitions for each exercise, the resistance exer-
cises will be made progressively harder using different
colour-graded elastic bands and tubing. Participants will
also be encouraged to perform each exercise (lifting phase -
concentric contraction) as rapidly as possible to optimise
movement speed and muscle power. The resistance exer-
cises to be incorporated into the program include: leg
abduction, plantar flexion, dorsi flexion, straight-leg/bent-
knee raise, knee extension and knee flexion. All resistance
exercises will be done in a seated position so the person
maintains a comfortable position while still receiving
hemodialysis treatment. The AEP will conduct the program
once per week for each participant over the intervention
period. Participants will also be encouraged to perform
the exercises during the two hemodialysis treatments
where the AEP is not present. The AEP will provide
training about the correct technique and progressions
for each exercise to nurses in the hemodialysis clinic so
that they can monitor patients on days when they are
not present. Adherence rates will be recorded by thenursing staff using a tick box on the patient’s daily
hemodialysis treatment record and daily exercise cards
completed by the participants, both of which will be
reviewed weekly by the AEP.
Data collection
Baseline data (Time 1) for all participants will be col-
lected 12 weeks prior to the commencement of the
intervention for the first group. The second round of
data collection (Time 2) will be conducted 12 weeks
later and participants from the five clinics randomised
to receive 36 weeks of intervention (Group 1) will com-
mence the exercise intervention. The third round of data
collection (Time 3) will be conducted 12 weeks later and
participants from the five clinics randomised to receive
24 weeks of intervention (Group 2) will commence the
exercise intervention. The fourth round of data collec-
tion (Time 4) will be conducted 12 weeks later and par-
ticipants from the five clinics randomised to receive
12 weeks of intervention (Group 3) will commence the
exercise intervention. The final round of data collection
will be conducted in the week after the intervention
ceases in all clinics, 48 weeks after the first data is col-
lected (Time 5) (Table 1).
Primary outcome measure
Objective physical function is the primary outcome
measure in this study and will be measured using the
30-second sit to stand test. The test will follow the
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and Temple [14], and is a simple, non-invasive test that
can be conducted with minimal equipment in the
hemodialysis clinic. The 30-second sit to stand test has
been validated for use with older people and people with
chronic disease [13,14]. Tests will be conducted before
participant’s midweek hemodialysis treatment every
12 weeks from the start date by an AEP who is blinded to
the intervention group.
Secondary measures
Secondary outcome measures will include two further
physical function tests (the eight foot timed up and go
test and the four square step test), quality of life, com-
munity activity involvement, dialysis exercise adequacy,
falls and falls confidence, medication use, biochemical
measures, morbidity and cost. Quality of life will be
measured at every 12 weeks from study commencement
using the validated Kidney Dialysis and Quality of Life
Index (KDQOL) [15]. KDQOL reliability and validity
have been confirmed in the hemodialysis population
[15]. Uptake and involvement in community activities
such as shopping, social outings, and gardening will be
measured using the Frenchay Activities Index (FAI)
every 12 weeks from study commencement. The FAI has
been validated in people with chronic disease [16]. Dialy-
sis Exercise Adequacy (DEA) will be measured every
12 weeks from study commencement using the formula:
weekly exercise frequency (number of times) × time
(hrs) × age/100 [17]. This will include exercise both
within and outside of the intervention and will identify
any change in the uptake of overall exercise over the
course of the study. Self-reported falls will be measured
every 12 weeks from study commencement by asking
each participant if they had any falls in the past 12 weeks,
how many falls they had over four weekly periods, and
whether an injury was sustained, based on the falls
reporting method used in the Mobilize Boston Study
[18]. In this study, a fall will be defined as “an event,
which results in a person coming to rest inadvertently
on the ground or other lower level” [19]. In addition,
falls confidence will be measured every 12 weeks from
study commencement using the Modified Falls Efficacy
Scale [20]. Participant use of medication in terms of the
number and type of medications will be extracted from
medication charts. This information will be collected at
the commencement of the intervention for each group
(Time 2, 3 or 4), and at the completion of the study
(Time 5). Biochemical and dialysis-related data routinely
measured during hemodialysis (i.e., mid-week post-
dialysis weight, mid-week pre and post sitting blood pres-
sure) will be recorded every 12 weeks from study com-
mencement. Morbidity will be measured by number of
hospital admissions, reason for hospital admission andlength of stay and will be recorded for all participants for
the duration of the study. This information will be
obtained verbally from the participant every 12 weeks from
study commencement. If clarification is required (i.e., par-
ticipant is unable to recall details), further information may
be sought from the participants’ hemodialysis treatment
progress record that is kept in the hemodialysis clinic.
Medication and morbidity data will contribute to cost
utility analysis. Unit costs will be derived from data
obtained from Medicare Australia regarding Medicare
Benefits Schedule (MBS) and Pharmaceutical Benefits
Scheme (PBS) claims (i.e., net cost, rebate, gap payment)
for each participant for the study duration, and from
Australian Refined Diagnosis Related Groups (AR-DRG)
cost weights [21]. Participants will also be asked if they
have accessed any health services that are not recorded
via Medicare (e.g., physiotherapy, district nursing) every
12 weeks, to more accurately estimate their health-
related costs. Quality adjusted life years (QALYs) effect
will be estimated using the SF-6D algorithm for KDQOL
data [22] and an Incremental Cost Effective Ratio (ICER)
will be calculated [23].
Study flow
The study flow is detailed in Figure 1. Firstly clinics will
be randomized to group 1, 2 or 3. After participants are
screened for eligibility based on the inclusion/exclusion
criteria and provide written informed consent, they will
undergo baseline physical function tests 12 weeks prior
to the commencement of the intervention. At the com-
pletion of these tests, the investigator will explain and
ask the participant to take home the combined question-
naire which will include the KDQOL, FAI, Boston Falls
Calender and the modified falls efficacy scale. Partici-
pants will be asked to complete these questionnaires and
return them at their next dialysis visit. Data obtained will
be transcribed onto case record forms for entry into a
specifically designed trial database. Data analysis will
then be undertaken by an investigator who is blinded to
the group intervention. The data collection plan is de-
tailed in Table 1.
Study withdrawal
Participants can withdraw from the intervention at any
stage, effective immediately, without affecting clinical
care as documented and explained at time of consent.
Participants who withdraw will be invited to consent to
follow-up testing for the remainder of the trial to enable
an intention-to-treat data analysis.
Sample size calculation
The 30 second sit-to-stand test is the most clinically
meaningful primary outcome measure and was used in
the sample size calculations for this study. It is clinically
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disease on hemodialysis have great difficulty simply get-
ting out of bed or out of a chair. This inability to stand
quickly from a chair is associated with their poor muscle
condition [24,25] and renal bone disease [26]. Likely ef-
fect sizes have been estimated from the sit-to-stand test
data from two previous studies [27,28]. In Cappy et al.
[27] the effect sizes (d) for the three, six, and twelve-
month changes in reps were 0.65, 1.12, and 2.39, re-
spectively. In McDonald et al. [28] the effect size (d) for
the 12-week change was 2.42. We chose the most con-
servative findings with the lowest effect size (Cappy’s 3-
month change: d = 0.65) for the sample size calculations.
Cappy et al. [27] demonstrated a medium-sized effect
for the effect of a physical activity intervention (d = 0.65),
alpha was set at p < 0.0125 (an adjustment was made to
the typical level of p < 0.05 for judging statistical signifi-
cance in these types of studies, because there will be a test
at each of four time points and we wish to control experi-
ment wise error). Power was set at .80. Based on our pre-
vious pilot work a 30% attrition rate over 12 months is
expected [10]. A design effect (DE = 1.25) was included to
account for clustering (ICC = .029, m = 9.73). The intra-
cluster correlation coefficient was estimated from prior
work with people with diabetes in primary care practices:
ICC = .029 [29]. We will require 15 clusters, with each
cluster representing one hemodialysis clinic. Based on
these assumptions, 180 participants will need to be
recruited for the study. Thus in each of the 15 clinics we
will need to recruit a minimum of 12 participants.
Statistical analyses
For the primary outcome measure there will be five data
collection points, one every 12 weeks as follows: Time 1
(0 weeks, no intervention), Time 2 (12 weeks, Group 1
commences intervention), Time 3 (24 weeks, Group 2
commences intervention), Time 4 (36 weeks, Group 3
commences intervention) and Time 5 (48 weeks, inter-
vention completed). This design characteristic means
analyses will occur at three time points (Time 3 to Time
5) with the data at each of these time points compared
with baseline data. Three tests means that the standard
α value (p < 0.05) will need to be divided by three (a
Bonferroni adjustment): α = .05/3 = .0167. Initially, ana-
lyses of variance with baseline scores as co-variates
(ANCOVAs) will be the method of analysis. In addition,
to account for the clustering effect, generalised linear
mixed models with random effects will be used to ana-
lyse differences between control period and intervention
period.
Discussion and conclusion
The primary outcome for this study is to examine the
effect of an AEP-coordinated resistance exerciseintervention on hemodialysis patients’ physical function.
A secondary associated outcome is the cost utility of exer-
cise physiologists together with community activity in-
volvement, dialysis exercise adequacy, falls and falls
confidence, medication use, biochemical measures and
morbidity. The importance of these measures is significant
given the paucity of uptake of exercise in hemodialysis
clinics worldwide. Exercise physiologists have increasingly
been involved in the improved outcomes of people with
chronic conditions; however, this has not been tested in
the hemodialysis population. This study will provide an im-
proved understanding on the impact of an AEP-co-
ordinated resistance exercise intervention and whether it is
a cost effective model for health services providing
hemodialysis.
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